Hege Hellstrom
Förmögenhet: 258 619 $ per 2026-08-31
Förmögenhet: 258 619 $ per 2026-08-31
Hege Hellstrom is the founder of Belnor BV.
Current jobs include Independent Director at Camurus AB since 2020, Independent Non-Executive Director at Vivesto AB since 2019, Director at Jane Goddall Institute Belgium, Independent Non-Executive Director at InflaRx NV since 2023, and Chief Commercial Officer at Advicenne SA since 2021.
Former jobs include Independent Director at Guard Therapeutics International AB, General Manager at Genzyme AB, President-EMENAR at Swedish Orphan Biovitrum AB from 2013 to 2018, and Head-Cardiovascular Unit & Regional Liaisons at Sanofi AB. Education includes undergraduate and doctorate degrees from Ullevaal School of Bioengineering and an undergraduate degree from Oslo Metropolitan University conferred in 1985.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CAMURUS AB 0,01 % | 2026-02-18 | 4 250 ( 0,01 % ) | 258 619 $ | 2026-08-31 |
INFLARX N.V. -.--% | 2026-03-18 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| VIVESTO AB | Direktör/Styrelseledamot | 2019-09-26 |
| CAMURUS AB | Direktör/Styrelseledamot | 2020-05-07 |
| ADVICENNE | Företagsledare/Principal | 2021-12-01 |
| INFLARX N.V. | Direktör/Styrelseledamot | 2023-04-01 |
Belnor BVBA | Grundare | - |
Jane Goddall Institute Belgium | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | President | 2018-01-01 |
| DISRUPTIVE PHARMA AB | Direktör/Styrelseledamot | - |
Sanofi AB
Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment | Företagsledare/Principal | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 12 |
|---|---|
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Vivesto AB
Vivesto AB Pharmaceuticals: GenericHealth Technology Develops cancer drugs based on nanotechnology for human and veterinary use | Health Technology |
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Develops and manufactures specialty therapeutic, surgical and diagnostic products | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Advicenne SA
Advicenne SA Pharmaceuticals: GenericHealth Technology Develops and markets pediatric drugs | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
Sanofi AB
Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment | Distribution Services |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Oslo Metropolitan University
Oslo Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ullevaal School of Bioengineering
Ullevaal School of Bioengineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Belnor BVBA | |
Jane Goddall Institute Belgium |
Välj din utgåva
All finansiell information anpassad till den nationella nivån